Interleukin-6 in idiopathic multicentric Castleman’s disease after long-term tocilizumab
Sign Up to like & getrecommendations! Published in 2017 at "Annals of Hematology"
DOI: 10.1007/s00277-017-3111-x
Abstract: Dear Editor, Idiopathic multicentric Castleman’s disease (iMCD) is a poorly understood lymphoproliferative disorder driven by the overrepresentation of interleukin (IL)-6 [1–5]. Since IL-6 plays a central role in the pathogenesis of iMCD, the normalization of… read more here.
Keywords: median level; range; long term; disease ... See more keywords